Capricor Therapeutics IncNASDAQ:CAPR
- LAST PRICE3.4200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.4000/ 3
- Ask / Lots3.4700/ 5
- Open / Previous Close3.3300 / 3.4200
- Day Range
- 52 Week Range
- Volume142,323
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CAPR |
|---|---|---|
| 09:32 ET | 396 | 3.33 |
| 09:51 ET | 400 | 3.35 |
| 09:55 ET | 100 | 3.35 |
| 09:57 ET | 250 | 3.3322 |
| 10:00 ET | 1792 | 3.34 |
| 10:04 ET | 100 | 3.35 |
| 10:06 ET | 100 | 3.35 |
| 10:08 ET | 100 | 3.35 |
| 10:18 ET | 100 | 3.44 |
| 10:22 ET | 300 | 3.48 |
| 10:24 ET | 5296 | 3.44 |
| 10:26 ET | 300 | 3.44 |
| 10:27 ET | 1000 | 3.35 |
| 10:29 ET | 3133 | 3.3101 |
| 10:31 ET | 810 | 3.44 |
| 10:33 ET | 5000 | 3.38 |
| 10:36 ET | 684 | 3.405 |
| 10:38 ET | 100 | 3.405 |
| 10:40 ET | 500 | 3.4223 |
| 10:49 ET | 200 | 3.42 |
| 10:54 ET | 200 | 3.42 |
| 10:58 ET | 11400 | 3.365 |
| 11:02 ET | 100 | 3.38 |
| 11:09 ET | 100 | 3.4 |
| 11:12 ET | 100 | 3.4 |
| 11:14 ET | 100 | 3.38 |
| 11:16 ET | 193 | 3.36 |
| 11:18 ET | 100 | 3.38 |
| 11:21 ET | 100 | 3.35 |
| 11:23 ET | 500 | 3.38 |
| 11:25 ET | 10516 | 3.42 |
| 11:27 ET | 100 | 3.44 |
| 11:39 ET | 165 | 3.44 |
| 11:41 ET | 300 | 3.435 |
| 11:43 ET | 300 | 3.435 |
| 11:48 ET | 100 | 3.46 |
| 11:50 ET | 200 | 3.44 |
| 11:54 ET | 8959 | 3.44 |
| 11:56 ET | 300 | 3.44 |
| 11:57 ET | 100 | 3.44 |
| 11:59 ET | 100 | 3.44 |
| 12:06 ET | 200 | 3.44 |
| 12:10 ET | 100 | 3.44 |
| 12:12 ET | 100 | 3.44 |
| 12:14 ET | 100 | 3.44 |
| 12:19 ET | 300 | 3.45 |
| 12:21 ET | 250 | 3.4496 |
| 12:26 ET | 120 | 3.44 |
| 12:28 ET | 100 | 3.44 |
| 12:30 ET | 100 | 3.44 |
| 12:33 ET | 200 | 3.46 |
| 12:35 ET | 100 | 3.45 |
| 12:37 ET | 3420 | 3.4101 |
| 12:44 ET | 100 | 3.435 |
| 12:46 ET | 1000 | 3.4336 |
| 12:50 ET | 3100 | 3.46 |
| 12:55 ET | 400 | 3.46 |
| 12:57 ET | 100 | 3.46 |
| 01:00 ET | 200 | 3.4319 |
| 01:02 ET | 100 | 3.46 |
| 01:04 ET | 400 | 3.44 |
| 01:06 ET | 100 | 3.44 |
| 01:08 ET | 100 | 3.44 |
| 01:11 ET | 800 | 3.46 |
| 01:13 ET | 260 | 3.42 |
| 01:15 ET | 10800 | 3.43 |
| 01:20 ET | 300 | 3.425 |
| 01:27 ET | 100 | 3.44 |
| 01:29 ET | 5400 | 3.41 |
| 01:31 ET | 500 | 3.43 |
| 01:33 ET | 700 | 3.44 |
| 01:36 ET | 100 | 3.44 |
| 01:38 ET | 100 | 3.44 |
| 01:44 ET | 100 | 3.44 |
| 01:45 ET | 1100 | 3.44 |
| 01:47 ET | 105 | 3.44 |
| 01:51 ET | 3605 | 3.42 |
| 01:54 ET | 2900 | 3.41 |
| 01:56 ET | 100 | 3.41 |
| 01:58 ET | 100 | 3.41 |
| 02:00 ET | 4300 | 3.38 |
| 02:02 ET | 421 | 3.39 |
| 02:03 ET | 1269 | 3.36 |
| 02:07 ET | 5984 | 3.399 |
| 02:12 ET | 100 | 3.41 |
| 02:14 ET | 1312 | 3.42 |
| 02:16 ET | 600 | 3.4225 |
| 02:18 ET | 100 | 3.4225 |
| 02:23 ET | 100 | 3.45 |
| 02:25 ET | 1000 | 3.4275 |
| 02:27 ET | 200 | 3.45 |
| 02:30 ET | 100 | 3.425 |
| 02:32 ET | 607 | 3.42 |
| 02:38 ET | 3196 | 3.42 |
| 02:39 ET | 100 | 3.425 |
| 02:41 ET | 100 | 3.425 |
| 02:43 ET | 100 | 3.425 |
| 02:50 ET | 1290 | 3.4 |
| 02:52 ET | 500 | 3.4225 |
| 02:54 ET | 200 | 3.425 |
| 03:03 ET | 200 | 3.42 |
| 03:06 ET | 100 | 3.4225 |
| 03:10 ET | 4800 | 3.401 |
| 03:14 ET | 100 | 3.42 |
| 03:15 ET | 100 | 3.42 |
| 03:26 ET | 200 | 3.41 |
| 03:28 ET | 100 | 3.43 |
| 03:33 ET | 100 | 3.43 |
| 03:35 ET | 400 | 3.42 |
| 03:37 ET | 100 | 3.42 |
| 03:39 ET | 100 | 3.42 |
| 03:42 ET | 100 | 3.42 |
| 03:44 ET | 929 | 3.42 |
| 03:46 ET | 500 | 3.42 |
| 03:50 ET | 100 | 3.42 |
| 03:51 ET | 400 | 3.42 |
| 03:53 ET | 800 | 3.41 |
| 03:55 ET | 855 | 3.42 |
| 04:00 ET | 1594 | 3.42 |
Nov 14, 2023
Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update, from 4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones*DJ Capricor Therapeutics 3Q Loss/Shr 25c >CAPR, from 4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
4:05PM ET on Tuesday Nov 14, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Capricor Therapeutics Inc | 102.8M | -3.0x | --- |
Nanopharmaceutics Inc | 105.8M | -181.0x | --- |
Shattuck Labs Inc | 101.5M | -1.1x | --- |
Reviva Pharmaceuticals Holdings, Inc. | 102.7M | -2.5x | --- |
BioXcel Therapeutics Inc | 104.5M | -0.5x | --- |
Kinnate Biopharma Inc | 102.7M | -0.8x | --- |
Company Information
Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). CAP-1002 is designed to slow disease progression in DMD through the immunomodulatory, anti-inflammatory, and anti-fibrotic actions of cardiosphere-derived cells (CDCs), which are mediated by secreted exosomes laden with bioactive cargo. CAP-2003 is the name of its exosomes product candidate, which is derived from its CDCs. It is also developing its exosome technology as a therapeutic platform. The Company’s focus is on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA), as well as proteins to treat or prevent a variety of diseases.
Contact Information
- Headquarters
- 8840 Wilshire Blvd, 2nd FloorBEVERLY HILLS, CA, United States 90211
- Phone
- 310-358-3200
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Frank Litvack
- President, Chief Executive Officer, Director
- Linda Marban
- Chief Financial Officer
- Anthony Bergmann
- Executive Vice President, General Counsel
- Karen Krasney
- Director
- Paul Auwaerter
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $102.8M |
|---|---|
Revenue (TTM) | $14.0M |
Shares Outstanding | 30.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.84 |
EPS | $-1.15 |
Book Value | $0.47 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -219.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
